abstract |
The present invention relates to compounds of formula (I) wherein the substituents are as defined in the claims. The compounds are vitronectin receptor antagonists and inhibitors of cell adhesion. The invention also relates to a process for the preparation of the compounds, to pharmaceutical compositions containing the compounds and to the use of the compounds. SHE |